Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Göteborg University | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether extensive internet based cognitive behavior treatment program with guidance is a more effective method to treat individuals with alcohol use disorders than a briefer cognitive behavior treatment program without guidance.
Two Internet based programs based on cognitive behavioral therapy and relapse prevention are evaluated among Internet help seekers, and compared to a waiting list. The design is a three armed randomized controlled trial, and outcomes are measured in terms of changes in alcohol consumption (mean consumption/week, number of heavy drinking days/week), problematic alcohol use, self efficacy, craving, as well as depression, anxiety and quality of life. In addition to this, the following instruments will be used as predictors: ASRS (ADHD), Hp5i (personality assessment). TIC-P, an instrument measuring cost effectiveness will also be used. Treatment Credibility and Adverse Events will also be assessed, the former once during the third week of treatment, and the latter once half way through treatment and once after treatment.
Primary hypothesis is that the more extended program with guidance (group 1) is more effective in reducing mean alcohol consumption and number of heavy drinking days compared to the briefer program with no guidance (group 2), as well as compared to a waiting list (group 3). A responder to treatment is defined as a participant drinking less than 9 (women)/ 14(men) glasses per week and no more than 3 (women)/4 (men) glasses per drinking day during that week.
A minimum of 169 participants will be recruited in two phases: first through an online screening and then through a diagnostic telephone assessment, where SCID will be used to diagnose Alcohol Use Disorders and MINI will be used to diagnose other psychiatric diagnoses. The telephone assessment and all guidance will be conducted by licensed psychologists or master students in psychology under supervision by licensed psychologists.
Included participants will be randomized into three groups:
Group 1: All participants in this group will have access to an extended cognitive behavioral treatment program and have access to a guide with basic training in psychotherapy (CBT) who assists and counsels the participant throughout the program.
Group 2: Participants in this group will have access to a briefer cognitive behavior treatment program with no access to a guide.
Group 3: Participants in this group will be placed on a waiting list for 12 weeks. Thereafter, they will be given access to the same extended cognitive behavior treatment program as Group 1; they will also be offered a possibility to choose between three guidance options: Choice 1: guide with intensive support, Choice 2: guide with support only at request, Choice 3: no guide.
Interim analyses will be undertaken in May 2016 by graduate students in Clinical psychology writing their MSc theses.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Extended self-help program with guidance | Experimental | The program is a comprehensive CBT program lasting 12 weeks, with as many modules. The modules are quite extensive. A guide with basic education in psychotherapy assists and counsels participants online. |
|
| Briefer Self-help program, no guidance | Active Comparator | This self-help program also lasts 12 weeks but contains only 9 modules; a pause occurs during the final weeks of the program for self-testing of acquired skills. The modules are quite brief. Participants receive no guidance. |
|
| WL: Extended self-help program, choice of guidance intensity | Other | Participants will be put on a waiting list. After 12 weeks on the waiting list, participants will receive access the the extended self-help program used in the experimental arm. However, participants will be offered a choice between three guidance options of varying intensity: proactive guidance, reactive guidance (only at participant request) or no guidance. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Extended self-help program with guidance | Behavioral | See arm description for Experimental |
|
| Measure | Description | Time Frame |
|---|---|---|
| Time Line Follow Back | Number of standard drinks during preceding week (using the Time Line Follow Back) | Screening; Changes before treatment, Post-treatment (12 weeks); and changes after 3-, 12-, and 24-months post-treatment |
| Time Line Follow Back | Days of heavy drinking during preceding week (using the Time Line Follow Back) | Screening; Changes before treatment, Post-treatment (12 weeks); and changes after 3-, 12-, and 24-months post-treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Alcohol Use Disorders Identification Test | assessement of alcohol use problems | Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment |
| Alcohol Abstinence Self Efficacy Scale |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anne H Berman, PhD | Karolinska Institutet | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Karolinska Institutet | Stockholm | 11364 | Sweden |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000437 | Alcoholism |
| ID | Term |
|---|---|
| D019973 | Alcohol-Related Disorders |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D003376 | Counseling |
| ID | Term |
|---|---|
| D008605 | Mental Health Services |
| D004191 | Behavioral Disciplines and Activities |
| D003153 | Community Health Services |
| D006296 | Health Services |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Briefer Self-help program, no guidance | Behavioral | See arm description for Active Comparator |
|
|
| WL: Extended self-help program, choice of guidance intensity | Behavioral | See arm description for Waiting list. |
|
|
instrument measuring self-efficacy
| Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment |
| Penn Alcohol Craving Scale | instrument measuring craving for alcohol | Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment |
| Montgomery Asberg Depression Rating Scale | instrument measuring depression | Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment |
| Euro-QOL 5 D | instrument measuring quality of life | Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment |
| Generalized Anxiety Disorder-7 | instrument measuring anxiety | Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment |
| Trimbos and iMTA questionnaire on cCosts associated with Psychiatric illness (TiC-P) | Instrument measuring health care consumption and cost-effectiveness (Bouwmans et al., 2013 | Screening, 12 months, 24 months post-treatment |
| Self-report questionnnaire on satisfaction with internet treatment usability features | This instrument contains 40 questions about satisfaction with various features of the internet-based treatment. Results will be analyzed on an aggregated group level. The questionnaire was constructed by the Internet psychiatry clinic in Stockholm. | Post-treatment (12 weeks after before-treatment measure) |
| Adult ADHD Self Report Scale (ASRS) | Screening of ADHD symptoms to be used as predictor of treatment outcome | Screening |
| Health-relevant Personality traits from a Five-factor perspective (hp5i) | Screening of personality traits to be used as predictor of treatment outcome | Screening |
| Adverse Events | Brief questionnaire with questions about any negative side effects of the treatment | Halfway through treatment (6 weeks after before-treatment measure) and post-treatment (12 weeks after before-treatment measure) |
| Treatment Credibility Scale | Brief questionnaire about if the treatment this far is perceived as effective | 3 weeks after before-treatment measure |
| SCID- section of Alcohol Use Disorders (adjusted to DSM5) | Diagnostic interview via telephone, diagnostic criteria of Alcohol Use Disorders (this will be undertaken if resurces allow). This will be a masked assessment, the interviewer will not know which original group the participant was randomized to | Screening interview, 12 and 24 months post-treatment |
| D005159 | Health Care Facilities Workforce and Services |